HLB Genex, Inc.

Research HLB Genex, Inc. (187420.KQ) on Bullrun: market cap KRW 81.61B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 81.61B.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 81.61Bn/an/an/a

Dividend history

About HLB Genex, Inc.

HLB Genex, Inc. engages in the research and development, production, import/export, and sale of enzymes and fermentation products in South Korea and internationally. Its industrial special enzyme products include lactase; catalase for use in semiconductor industry; and proteinase K for molecular diagnostics and genetic engineering experiments, as well as bio-health care ingredients comprise N-phytosphingosine and vitamin K2.

Related stock research

South Korea stocks South Korea Basic Materials stocks A-Z stock index

Other Basic Materials stocks

Deokyang Energen Corporation (0001A0.KQ) NOROO Holdings Co., Ltd. (000320.KS) SP Samhwa Co., Ltd. (000390.KS) Kangnam Jevisco Co., Ltd (000860.KS) Bowon Chemical Co., Ltd. (0010F0.KQ) Paikkwang Industrial Co.,Ltd (001340.KS) Bolak Company Limited (002760.KS) Songwon Industrial Co., Ltd. (004430.KS) Chokwang Paint Ltd. (004910.KS) Cosmo Advanced Materials & Technology Co., Ltd. (005070.KS) Cosmo Chemical Co., Ltd. (005420.KS) Kukdo Chemical Co., Ltd. (007690.KS)

Frequently asked questions

What is HLB Genex, Inc.'s market cap?

HLB Genex, Inc.'s market capitalization is KRW 81.61B.

What does HLB Genex, Inc. do?

HLB Genex, Inc. engages in the research and development, production, import/export, and sale of enzymes and fermentation products in South Korea and internationally. Its industrial special enzyme products include lactase; catalase for use in semiconductor industry; and proteinase K for molecular diagnostics and genetic engineering experiments, as well as bio-health care ingredients comprise N-phytosphingosine and vitamin K2.